[FMI] Foundation Medicine, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical Specialities

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 19.7 Change: 0.7 (3.68%)
Ext. hours: Change: 0 (0%)

chart FMI

Refresh chart

Strongest Trends Summary For FMI

FMI is in the long-term up 504% in 3 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Foundation Medicine, Inc. provides various molecular information products in the United States. Its molecular information platform generates actionable genomic information about a patient?s individual disease, enabling physicians to optimize treatments in clinical practice, and enabling biopharmaceutical companies to develop targeted oncology therapies. The company offers clinical products, such as FoundationOne for solid tumors; and FoundationOne Heme, for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and myeloma, as well as sarcomas and pediatric cancers. It has strategic collaboration agreement with WuXi PharmaTech (Cayman) Inc. to provide genomic profiling to biopharmaceutical companies conducting clinical trials. The company was founded in 2009 and is headquartered in Cambridge, Massachusetts.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 33.11% Sales Growth - Q/Q3.29% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-52.87% ROE-76.22% ROI
Current Ratio3.46 Quick Ratio3.26 Long Term Debt/Equity Debt Ratio0.31
Gross Margin54.93% Operating Margin-84.32% Net Profit Margin-82.74% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities3.88 M Cash From Investing Activities-3.34 M Cash From Operating Activities-10.92 M Gross Profit13.51 M
Net Profit-33.05 M Operating Profit-33.06 M Total Assets322.8 M Total Current Assets289.55 M
Total Current Liabilities22.14 M Total Debt Total Liabilities322.8 M Total Revenue22.46 M
Technical Data
High 52 week137 Low 52 week33.3 Last close137 Last change0%
RSI69.7 Average true range0.14 Beta1.14 Volume110.83 K
Simple moving average 20 days0.15% Simple moving average 50 days12.04% Simple moving average 200 days69.62%
Performance Data
Performance Week0.15% Performance Month0.22% Performance Quart87.93% Performance Half97.41%
Performance Year291.99% Performance Year-to-date100.88% Volatility daily0.06% Volatility weekly0.14%
Volatility monthly0.29% Volatility yearly1% Relative Volume604.13% Average Volume652.34 K
New High New Low

News

2018-09-24 10:41:15 | With new blood test, Roche dives deeper into personal cancer care

2018-09-12 09:11:01 | Incyte, Foundation Medicine Partner for Companion Diagnostics

2018-08-06 12:00:00 | Foundation Medicine Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden bTMB as a Novel Predictor of Response to Cancer Immunotherapy

2018-07-31 09:01:01 | Roche Purchases Shares in Tender Offer for FMI

2018-07-27 07:45:00 | Breakfast Technical Briefing on TrovaGene and Three Other Additional Medical Research Stocks

2018-07-27 07:45:00 | New Research: Key Drivers of Growth for Cadence Design, Agenus, Foundation Medicine, Honeywell International, NeoPhotonics, and Citrix — Factors of Influence, Major Initiatives and Sustained Production

2018-07-18 16:00:00 | Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit

2018-07-05 08:47:00 | 3 Best Biotech Acquisitions of 2018 So Far

2018-07-02 11:36:02 | Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash

2018-06-25 13:29:00 | What Roche's Acquisition of Foundation Medicine Means for Investors

2018-06-22 09:52:01 | Pharma Stock Roundup: PTCT Unveils Promising Data, RHHBY to Acquire Rest of FMI

2018-06-22 09:20:00 | Big Biotech Stock Pops and Drops This Week

2018-06-22 07:30:07 | [$$] Gormley's Take: Precision-Medicine Drive Gathers Momentum

2018-06-20 13:20:00 | FOUNDATION MEDICINE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

2018-06-20 10:00:02 | Company News For Jun 20, 2018

2018-06-20 08:00:00 | Today’s Research Reports on Stocks to Watch: Foundation Medicine and Solid Biosciences

2018-06-20 03:51:07 | Roche to Buy Rest of Foundation Medicine for $2.4 billion

2018-06-20 00:15:24 | [$$] Jefferies’ great leap forward on Wall Street

2018-06-19 19:42:38 | [$$] Roche to Pay $2.4 Billion for Full Control of Foundation Medicine

2018-06-19 18:18:00 | WeissLaw LLP: Foundation Medicine, Inc. Acquisition May Not Be In The Best Interest of FMI Shareholders

2018-06-19 16:31:00 | Why CVS Health, Foundation Medicine, and Solid Biosciences Jumped Today

2018-06-19 16:30:55 | How A Merger Will Help These Two Firms Tailor Cancer Treatments

2018-06-19 12:48:31 | Roche Does Pharma M&A Without the Pharma

2018-06-19 12:39:00 | Why Foundation Medicine Stock Is Skyrocketing 28.3% Higher Today

2018-06-19 10:54:12 | Netflix expands, Amazon teams up with Marriott, Wells Fargo merging wealth management groups

2018-06-19 10:48:04 | Mattel, Foundation Medicine and Sirius are the Yahoo Finance Charts of the day.

2018-06-19 10:21:00 | Netflix expands and has price target raised, Amazon teams up with Marriott hotels, Wells Fargo merging wealth management groups

2018-06-19 08:58:20 | Stocks fall deep into the red as trade war escalates

2018-06-19 04:57:55 | [$$] European Corporate Roundup for Tuesday

2018-06-19 04:35:02 | Roche pays $2.4 billion for rest of cancer expert Foundation Medicine

2018-06-19 03:57:38 | [$$] Roche to Buy Rest of Foundation Medicine

2018-06-19 01:01:00 | Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology

2018-06-19 00:09:44 | [$$] Roche to spend $2.4bn buying rest of Foundation Medicine

2018-06-18 23:54:37 | [$$] Genomics/Roche: precision vision

2018-06-05 07:00:00 | Foundation Medicine to Present at Upcoming Investor Conferences

2018-05-31 11:10:03 | 5 Top Performing Stocks of the Best ETF of May

2018-05-29 07:00:00 | Foundation Medicine and Collaborators to Present New Data at ASCO 2018 Supporting Comprehensive Genomic Profiling CGP to Inform Personalized Approaches in Cancer Care

2018-05-25 18:31:00 | 3 Stocks That Look Just Like eBay in 1998

2018-05-24 07:00:00 | Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck

2018-05-22 08:10:00 | Analysis: Positioning to Benefit within Front Yard Residential, Foundation Medicine, SPX FLOW, Silicon Laboratories, John Wiley & Sons, and Hub Group — Research Highlights Growth, Revenue, and Consolidated Results

2018-05-22 08:10:00 | Today's Research Reports on Trending Tickers: Celgene and Foundation Medicine

2018-05-21 07:00:00 | Foundation Medicine Receives New ADLT Status for FoundationOne CDx™ from the Centers for Medicare and Medicaid Services CMS

2018-05-11 08:16:00 | 3 Healthcare Stocks Growing Over 100%

2018-05-03 23:55:34 | Edited Transcript of FMI earnings conference call or presentation 2-May-18 8:30pm GMT

2018-05-02 17:36:41 | Foundation Medicine: 1Q Earnings Snapshot

2018-05-02 16:01:00 | Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights

2018-05-02 07:00:00 | Foundation Medicine Launches Gene Expression Profiling Program to Identify Known and Novel Biomarkers in Advanced Cancer

2018-04-26 21:35:54 | BRIEF-Dian Diagnostics In Separate Agreements With Foundation Medicine, F. Hoffmann-La Roche

2018-04-26 18:00:00 | Foundation Medicine, Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China

2018-04-26 07:00:00 | Foundation Medicine’s New Liquid Biopsy Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration